Related Experiment Video
Updated: Jul 18, 2025

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.5K
Lacunes are associated with late-stage multiple sclerosis comorbidities
Lijie Zhang1,2, Xintong Yu1,2, Yexiang Zheng1,2
1Department of Neurology and Institute of Neurology of The First Affiliated Hospital, Institute of Neuroscience, Fuzhou, China.
Frontiers in Neurology
|August 24, 2023
Summary
The duration of Multiple Sclerosis (MS) is the only identified risk factor for developing lacunes, which are small brain lesions. MS patients with lacunes experienced more attacks and larger T2 lesions.
Area of Science:
- Neurology
- Vascular Neurology
- Neuroimaging
Background:
- Multiple sclerosis (MS) is linked to vascular events and mortality, but its association with cerebral small vessel disease (CSVD) is unclear.
- Lacunes are a type of lesion indicative of CSVD.
Purpose of the Study:
- To investigate the relationship between MS and the presence of lacunes.
- To identify risk factors for lacune development in MS patients.
Main Methods:
- A prospective observational study included 112 participants (46 with MS, 66 with CSVD).
- MRI (T2-weighted, T1-weighted, FLAIR) and neurological assessments were performed.
- Lacunes and black holes were identified via image analysis.
Main Results:
- Lacunes were present in 19.6% of MS patients.
- MS duration was the sole significant risk factor for lacunes (OR=1.3, CI=1.1-1.6, p=0.008).
- MS patients with lacunes had more attacks and larger T2 lesion volumes.
- Lacune lesions showed limited ability to differentiate MS from CSVD after 6 years of disease duration.
Conclusions:
- Disease duration is a key factor in lacune development in MS.
- Lacunes may indicate underlying small arterial disease in MS patients.
- Further research is needed to clarify the MS-CSVD relationship.
Related Concept Videos
Alzheimer's Disease: Overview
518
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
518
Parkinson's Disease: Overview
596
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
596
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K
Long-term Potentiation
55.3K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
55.3K

